Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study: IMPETUS 2018 - TREAT

NCT03113006 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT03113006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03113006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study: IMPETUS 2018 - TREAT
Lead sponsor
Odense University Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2017
Completion date
August 27, 2019
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, pdr, proliferative diabetic retinopathy